
Now that Arbutus Biopharma Corp’s volume has hit 1.81 million, investors get a glimpse of its size.
On Tuesday, Arbutus Biopharma Corp (NASDAQ: ABUS) was -1.17% drop from the session before settling in for the closing price of $3.41. A 52-week range